Scientific Communications Officer for COSMIC, Wellcome Sanger Institute
BIOGRAPHY
Speakers
-
Alex Holmes, Ph.D.
Senior Curator for COSMIC, Wellcome Sanger InstituteBIOGRAPHY -
Jennifer Wilding, Ph.D.
Scientist Curator for COSMIC, Wellcome Sanger InstituteBIOGRAPHY
Event Date & Time
Date: December 7, 2023
Time: 8:00 AM (PST), 11:00 AM (EST), 5:00 PM (CET)
Abstract
As the vast landscape of genetic oncology continues to expand, the ability to understand and utilize the full potential of this rich data becomes increasingly challenging. As a result, researchers, scientists, and clinicians need an accessible, streamlined and standardized way of keeping track of this potentially crucial, ever-growing body of actionable knowledge. Over the course of 20 years, COSMIC, the Catalogue Of Somatic Mutations In Cancer, has expertly curated the world’s largest, most comprehensive database for somatic mutation information relating to human cancer. Today, COSMIC is used worldwide by revered research and clinical institutes, biotech and pharmaceutical companies, and more.
In this webinar, Leonie Hodges, Scientific Communications Officer for COSMIC, will delve into the wide range of datasets that COSMIC offers, detailing the content, how to obtain actionable insights from the genomic data, and how to potentially use this data for real-world applications. Following the talk, there will be a live Q&A with Jennifer Wilding, Scientist Curator at COSMIC and Alex Holmes, Senior Database Curator at COSMIC.
By attending this webinar, you will learn how to:
- Explore the wide range of datasets that COSMIC offers, including the Cancer Mutation Census and Mutational Signatures;
- Gain insights from COSMIC’s gold standard genomic data by taking either a disease or gene centric view of your research;
- Identify potential applications of COSMIC data and how it enables users from a plethora of disciplines to experiment and innovate with confidence.
Webinars will be available for unlimited on-demand viewing after live event.
You May Also Like
OCT 02, 2024 | 7:30 AM
De novo gene synthesis and protein expression are established technologies that can give access to nearly any target DNA or protein sequence, allowing for engineering of biologics. In this p...
DEC 10, 2024 | 9:00 AM
To-date, proteomic analysis has been severely limited in scale and resolution. Analyzing protein samples using an intact, single-molecule approach holds th...
Loading Comments...